The investigators noted cardiovascular events for up to 1 year post-discharge in 18.5% of RSV patients, compared with 17.7% ...

The US Senate yesterday confirmed Susan Monarez, PhD, as the new director of the Centers for Disease Control and Prevention ...

The mRNA COVID vaccine used this past season showed no elevated risk of any of the 29 serious adverse events assessed.